PVLA Palvella Therapeutics, Inc.

Fundamentals / CIK 0001583648 / USD

Palvella Therapeutics, Inc. reported $239.4M in total assets and a net loss of $74.99M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PVLA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$50.44M$25.22M$0-$46.70MFY 2016 Revenue: $5.83MFY 2016 Net Income: -$22.80M2016FY 2017 Revenue: $25.27MFY 2017 Net Income: -$17.65M2017FY 2018 Revenue: $29.10MFY 2018 Net Income: -$26.75M2018FY 2019 Revenue: $46.28MFY 2019 Net Income: -$25.47M2019FY 2020 Revenue: $29.32MFY 2020 Net Income: -$37.23M2020FY 2021 Revenue: $31.42MFY 2021 Net Income: -$45.74M2021FY 2022 Revenue: $25.90MFY 2022 Net Income: -$33.28M2022FY 2023 Revenue: $42.81MFY 2023 Net Income: $18.69M2023FY 2024 Net Income: -$17.43M2024FY 2025 Net Income: -$41.72M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- $42.81M $25.90M $31.42M $29.32M $46.28M $29.10M $25.27M $5.83M
Research & Development $22.84M $8.15M $8.79M $52.98M $66.66M $46.53M $55.00M $41.49M $22.29M $19.70M
Total Operating Expenses $38.60M $14.10M $11.87M $69.38M $83.25M $63.24M $73.44M $59.93M $39.87M $28.59M
Operating Income -$38.60M -$14.10M -$11.87M -$43.47M -$51.83M -$33.92M -$27.16M -$30.83M -$14.59M -$22.76M
EBITDA -- -- -$9.96M -$40.70M -$49.37M -$31.82M -$26.56M -$30.26M -$14.22M -$22.40M
Interest Expense $0 $430K $0 -- -- -- -- -- -- --
Income Before Tax -$41.72M -$17.43M $18.69M -$33.28M -$45.74M -$37.07M -$25.47M -$27.07M -$16.54M -$22.64M
Income Tax Expense $0 $0 $0 $0 $0 $164K $0 -$312K $1.10M $162K
Net Income -$41.72M -$17.43M $18.69M -$33.28M -$45.74M -$37.23M -$25.47M -$26.75M -$17.65M -$22.80M
Basic EPS -$3.71 -$7.83 $2.19 -$36.00 -$56.80 -$54.40 -$44.80 -$40.00 -$32.00 -$44.00
Diluted EPS -$3.71 -$7.83 $2.17 -- -$56.80 -$54.40 -$44.80 -$40.00 -$32.00 -$44.00
Basic Shares Outstanding 11.3M 2.2M 1.8M 927.1K 806.8K 681.0K 632.8K 663.5K 549.1K 521.4K
Diluted Shares Outstanding 11.3M 2.2M 1.8M -- 806.8K 681.0K 632.8K 663.5K 549.1K 521.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $10.82M $12.47M $9.33M $7.12M $6.53M $5.12M $4.07M $2.54M
Total Operating Expenses $22.73M $21.41M $14.86M $11.30M $10.18M $9.25M $7.87M $4.37M
Operating Income -$22.73M -$21.41M -$14.86M -$11.30M -$10.18M -$9.25M -$7.87M -$4.37M
Interest Expense -- -- -- -- $0 $0 -- --
Income Before Tax -$24.64M -$21.87M -$15.77M -$12.71M -$11.35M -$9.47M -$8.19M -$3.95M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$24.64M -$21.87M -$15.77M -$12.71M -$11.35M -$9.47M -$8.19M -$3.95M
Basic EPS -$1.70 -$1.52 -$1.20 -- -$1.03 -$0.86 -$0.74 --
Diluted EPS -$1.70 -$1.52 -$1.20 -- -$1.03 -$0.86 -$0.74 --
Basic Shares Outstanding 14.5M 14.4M 13.1M -- 11.1M 11.1M 11.0M --
Diluted Shares Outstanding 14.5M 14.4M 13.1M -- 11.1M 11.1M 11.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jan 1 Dec 31 Dec 31
Cash & Cash Equivalents $57.98M $83.60M $7.35M $38.63M $117.8M $70.44M $62.26M -- $74.87M $37.88M
Short-Term Investments $0 -- $8.97M $20.53M $0 $0 $41.89M -- $53.24M $34.75M
Cash & Short-Term Investments $57.98M $83.60M $26.40M $59.20M $117.8M $70.44M $104.2M -- $128.1M $72.63M
Accounts Receivable, Net $0 $358K $0 $5.81M $3.31M $1.71M $6.79M -- $2.70M $15.55M
Total Current Assets $58.99M $88.23M $7.55M $73.42M $127.6M $75.72M $115.0M -- $135.4M $89.79M
Property, Plant & Equipment, Net -- -- $0 $16.99M $19.12M $22.05M $19.50M -- $5.05M $4.03M
Long-Term Investments -- -- -- -- -- -- -- -- $0 $9.92M
Other Non-Current Assets -- -- $0 $1.37M $2.90M $3.31M $3.15M $2.03M $910K $130K
Total Non-Current Assets $572K $0 $0 $22.07M $25.93M $29.29M $26.08M -- $5.96M $14.09M
Total Assets $59.56M $88.23M $7.55M $95.49M $153.6M $105.0M $141.1M $143.2M $141.3M $103.9M
Accounts Payable $4.59M $4.59M $936K $4.15M $8.61M $1.79M $5.80M -- $3.35M $2.45M
Deferred Revenue (Current) -- -- $0 $20.82M $25.12M $12.63M $11.26M -- $35.61M $37.15M
Other Current Liabilities $705K $1.19M $169K -- -- -- -- -- -- --
Total Current Liabilities $11.34M $12.04M $2.36M $36.58M $50.56M $22.14M $27.00M -- $48.08M $45.77M
Deferred Revenue (Non-Current) -- -- $0 $18.73M $38.40M $35.90M $47.26M $56.78M $53.30M $46.54M
Other Non-Current Liabilities -- -- -- $0 $0 $6.0K $0 -- $27K $37K
Total Non-Current Liabilities $20.23M $13.59M $9.07M $30.98M $52.24M $51.84M $62.74M -- $53.33M $46.58M
Total Liabilities $31.58M $25.63M $11.43M $67.56M $102.8M $73.98M $89.75M $104.9M $101.4M $92.35M
Total Debt (incl. Leases) $633K -- -- $13.10M $14.89M $16.96M $16.22M $903K -- --
Common Stock $12K $11K $0 $74K $72K $56K $55K -- $54K $45K
Retained Earnings -$135.4M -$93.73M -$76.30M -$290.4M -$257.1M -$211.4M -$174.2M -$148.7M -$147.1M -$120.3M
Accumulated Other Comp. Income $83K $3.0K $0 -$254K $829K -$295K -$2.00M -- -$2.98M -$4.70M
Total Stockholders' Equity $27.98M $62.61M -$74.48M -$93.78M $50.76M $31.03M $51.35M $38.29M $39.94M $11.52M
Total Equity $27.98M $62.61M -$74.48M -$93.78M $50.76M $31.03M $51.35M $38.29M $39.94M $11.52M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $193.3M $187.8M $206.4M $57.98M $63.57M $70.43M $75.63M $83.60M
Short-Term Investments $43.38M $62.78M $55.46M $0 -- -- -- --
Cash & Short-Term Investments $236.7M $250.6M $261.9M $57.98M $63.57M $70.43M $75.63M $83.60M
Accounts Receivable, Net -- -- -- $0 $0 $0 $0 $358K
Total Current Assets $239.0M $253.0M $263.2M $58.99M $66.94M $73.75M $79.44M $88.23M
Total Non-Current Assets $435K $482K $528K $572K $0 $0 $0 $0
Total Assets $239.4M $253.5M $263.8M $59.56M $66.94M $73.75M $79.44M $88.23M
Accounts Payable $5.16M $6.79M $5.44M $4.59M $3.48M $4.56M $4.44M $4.59M
Other Current Liabilities $1.34M $1.24M $960K $705K $1.05M $925K $825K $1.19M
Total Current Liabilities $14.93M $11.95M $9.12M $11.34M $10.31M $9.62M $8.98M $12.04M
Total Non-Current Liabilities $26.55M $24.70M $22.33M $20.23M $17.94M $16.35M $14.88M $13.59M
Total Liabilities $41.48M $36.64M $31.45M $31.58M $28.25M $25.97M $23.86M $25.63M
Total Debt (incl. Leases) $485K $535K $584K $633K -- -- -- --
Common Stock $15K $14K $14K $12K $11K $11K $11K $11K
Retained Earnings -$197.7M -$173.1M -$151.2M -$135.4M -$122.7M -$111.4M -$101.9M -$93.73M
Accumulated Other Comp. Income $56K $89K $95K $83K $104K -$111K -$3.0K $3.0K
Total Stockholders' Equity $197.9M $216.9M $232.3M $27.98M $38.68M $47.78M $55.58M $62.61M
Total Equity $197.9M $216.9M $232.3M $27.98M $38.68M $47.78M $55.58M $62.61M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$41.72M -$17.43M $18.69M -$33.28M -$45.74M -$37.23M -$25.47M -$26.75M -$17.65M -$22.80M
Depreciation & Amortization -- -- $1.90M $2.77M $2.46M $2.10M $600K $570K $369K $361K
Stock-Based Compensation $6.40M $830K $603K $4.40M $5.21M $5.09M $5.37M $4.94M $3.05M $1.91M
Change in Receivables $387K $0 $5.31M -$2.62M -$1.81M $5.34M -$4.05M $12.51M -$14.47M -$59K
Change in Payables $1.26M $2.24M -$2.25M -$4.21M $7.05M -$4.35M $1.26M $764K -$332K $1.36M
Operating Cash Flow -$25.01M -$10.84M -$13.70M -$59.93M -$7.66M -$45.90M -$52.47M -$1.07M $49.75M -$14.39M
Capital Expenditure -- -- -$171K -$1.04M -$949K -$2.73M -$2.46M -$1.70M -$1.95M -$560K
Free Cash Flow -- -- -$13.87M -$60.97M -$8.61M -$48.62M -$54.93M -$2.76M $47.80M -$14.95M
Purchases of Investments -- -- -$22.84M -$48.40M $0 -$41.50M -$59.32M -$117.6M -$43.92M $0
Sales & Maturities of Investments -- -- -- -- -- $83.44M $71.62M $110.4M $0 --
Investing Cash Flow -- -- $12.00M -$21.24M -$949K $39.21M $9.84M -$8.88M -$45.88M -$560K
Common Stock Issued -- -- $19.73M $6.92M $38.19M $9.62M -- -- -- --
Financing Cash Flow -$660K $87.09M $5.00M $7.21M $59.13M $10.12M $32.17M $48.51M $4.09M $15.22M
Net Change in Cash -$25.62M $76.25M -$8.70M -$79.13M $47.33M $8.18M -$12.61M $36.99M $8.52M $6.0K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$24.64M -$21.87M -$15.77M -$12.71M -$11.35M -$9.47M -$8.19M -$3.95M
Stock-Based Compensation $5.42M $5.16M $3.38M $2.08M $1.79M $1.43M $1.09M $268K
Change in Receivables -- -- -- $29K $0 $0 $358K $0
Change in Payables -$1.71M $1.35M $851K $1.16M -$1.14M $116K $1.12M $43K
Operating Cash Flow -$14.43M -$12.85M -$10.86M -$4.93M -$7.88M -$5.43M -$6.77M -$5.39M
Purchases of Investments -$4.43M -$15.03M -$55.44M -- $0 $0 $0 --
Investing Cash Flow $19.57M -$7.03M -$55.44M -- $0 $0 $0 --
Common Stock Issued $0 $0 $230.0M -- $0 $0 $0 --
Financing Cash Flow $452K $1.28M $214.7M -$49K $242K $349K -$1.20M $74.78M
Net Change in Cash $5.49M -$18.59M $148.4M -$5.58M -$6.87M -$5.19M -$7.98M $69.39M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -27.7% -167.8% -165.0% -115.7% -58.7% -105.9% -57.7% -390.3%
Net Profit Margin -- -- 43.7% -128.5% -145.6% -127.0% -55.0% -91.9% -69.8% -391.0%
Return on Equity (ROE) -149.1% -27.8% -- -- -90.1% -120.0% -49.6% -67.0% -153.2% -90.4%
Return on Assets (ROA) -70.0% -19.8% 247.6% -34.8% -29.8% -35.5% -18.1% -18.9% -17.0% -65.0%
Current Ratio 5.20x 7.33x 3.20x 2.01x 2.52x 3.42x 4.26x 2.82x 1.96x 3.90x
Quick Ratio 5.11x 6.97x 11.19x 1.78x 2.39x 3.26x 4.11x 2.72x 1.93x 3.51x
Debt to Equity 0.02x -- -- -- 0.29x 0.55x 0.32x -- -- --
Revenue Growth (YoY) -- -- +65.3% -17.6% +7.1% -36.6% +59.0% +15.1% +333.5% +98.9%
Net Income Growth (YoY) -- -193.3% -- -- -- -- -- -- -- --
EPS Growth (YoY) -- -457.5% -- -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -102.1% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -105.8% -- --
5Y Revenue / Share Growth -- -- -44.9% -39.3% +248.2% +531.4% +136.4% -47.8% -- --
10Y Revenue / Share Growth -- -- -71.2% -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -9106.7% -- --
10Y Net Income / Share Growth -- -- +2258.5% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -37.9% -28.4% -21.2% -149.1% -85.2% -59.4% -41.5% -27.8%
Return on Assets (ROA) -31.3% -24.3% -18.7% -70.0% -49.2% -38.5% -29.1% -19.8%
Current Ratio 16.01x 21.18x 28.88x 5.20x 6.49x 7.67x 8.84x 7.33x
Quick Ratio 15.86x 20.98x 28.73x 5.11x 6.16x 7.32x 8.42x 6.97x
Debt to Equity 0.00x 0.00x 0.00x 0.02x -- -- -- --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -132.6%
Net Income Growth (YoY) -- -- -- -- -- -- -- -110.2%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -126.4%
Source: SEC EDGAR CompanyFacts (CIK 0001583648) · from June 30, 2013 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal